Today: 9 June 2026
Teradyne stock slides after AI-driven outlook rally — what traders watch next
4 February 2026
1 min read

Teradyne stock slides after AI-driven outlook rally — what traders watch next

New York, Feb 4, 2026, 12:01 EST — Regular session

Teradyne (TER.O) shares slipped roughly 4% to $271.69 by midday Wednesday, retreating after a strong rally fueled by the chip-testing equipment maker’s latest quarterly report earlier this week. During the session, the stock fluctuated between $269.99 and $295.02.

Teradyne’s pullback follows its upbeat forecast for first-quarter revenue and profit, announced Monday, which surpassed Wall Street’s estimates. The boost comes from robust spending on data-center expansion aimed at AI. The company gains as AI compute and memory chips become more complex and production schedules compress. Analysts often watch utilization rates at leading chip fabs for signs of new tester demand.

This is important because Teradyne operates near the heart of the semiconductor capital-spending cycle. Orders can spike rapidly as chipmakers ramp up equipment purchases, but they can vanish just as fast when budgets tighten.

Teradyne posted fourth-quarter revenue of $1.083 billion and non-GAAP earnings of $1.80 per share, it announced. Semiconductor Test pulled in $883 million, Product Test $110 million, and Robotics $89 million. For Q1, the company projects revenue between $1.15 billion and $1.25 billion, with non-GAAP earnings ranging from $1.89 to $2.25 per share. These adjusted figures strip out costs like acquired intangible amortization and restructuring charges. CEO Greg Smith attributed the quarter’s strength to AI-driven demand in compute, networking, and memory, adding that Teradyne anticipates year-over-year growth across all segments in 2026.

The results appeared in a Form 8-K submitted to the U.S. Securities and Exchange Commission.

Analysts called the forecast an “absolute blowout,” MarketWatch reported. Cantor Fitzgerald’s C.J. Muse and Bank of America’s Vivek Arya highlighted faster innovation and growing complexity in AI chip production and memory as key factors boosting test spending. MarketWatch

Teradyne’s testers put chips through their paces, verifying performance and reliability before shipment. But as designs cram more compute power and faster memory into smaller packages, testing becomes tougher. This is pushing buyers to invest heavily in AI-driven solutions.

Test equipment remains cyclical. If data-center spending slows or chipmakers delay production ramps, orders can drop, sending a stock that priced in robust quarters tumbling fast.

Investors are keen to see if order flow reveals anything new and if demand holds up past next quarter’s outlook. Teradyne is set to present at SEMICON Korea on Feb. 11 and then again at the Chiplet Summit on Feb. 17. These upcoming industry events often shed light on demand trends.

Stock Market Today

  • Factorial Energy Shares Surge After Nasdaq Ticker Change from Cartesian Growth
    June 9, 2026, 9:18 AM EDT. Factorial Energy (ticker FAC) began trading on Nasdaq after merging with Cartesian Growth Corporation III (CGCT), marking the SPAC's transition from a shell company to an operating battery tech firm. Shares surged 16% to $13.80 on June 8, with premarket quotes near $20.70 the next day. The merger valued Factorial at approximately $1.3 billion and raised over $100 million to support commercializing solid-state batteries, which offer improved range and safety over traditional lithium-ion cells. CEO Siyu Huang emphasized the listing will accelerate the company's development. Factorial focuses on validation milestones, with partnerships including Mercedes-Benz and Stellantis. The move positions Factorial alongside public battery tech firms like QuantumScape and Solid Power, amid investor reshuffling following the transaction.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Apple stock jumps as Goldman flags App Store spending pickup, keeping AAPL in focus
Previous Story

Apple stock jumps as Goldman flags App Store spending pickup, keeping AAPL in focus

Coinbase stock slides after Nevada lawsuit over sports event contracts; earnings ahead
Next Story

Coinbase stock slides after Nevada lawsuit over sports event contracts; earnings ahead

Go toTop